Lionel Perrier : Citation Profile


Are you Lionel Perrier?

Université de Lyon

2

H index

0

i10 index

18

Citations

RESEARCH PRODUCTION:

4

Articles

105

Papers

RESEARCH ACTIVITY:

   16 years (2002 - 2018). See details.
   Cites by year: 1
   Journals where Lionel Perrier has often published
   Relations with other researchers
   Recent citing documents: 0.    Total self citations: 2 (10 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/ppe847
   Updated: 2022-08-13    RAS profile: 2018-01-23    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Havet, Nathalie (5)

Authors registered in RePEc who have co-authored more than one work in the last five years with Lionel Perrier.

Is cited by:

Dekker, Rommert (4)

Bessho, Shun-ichiro (2)

Tronstad, Russell (1)

Persson, Emil (1)

Ibuka, Yoko (1)

Cites to:

Lichtenberg, Frank (2)

Todd, Petra (2)

Smith, Jeffrey (2)

Wübker, Ansgar (1)

McDonald, John (1)

Gravelle, Hugh (1)

Schmitz, Hendrik (1)

Moffitt, Robert (1)

Holle, Rolf (1)

Main data


Where Lionel Perrier has published?


Journals with more than one article published# docs
Health Policy2

Working Papers Series with more than one paper published# docs
Post-Print / HAL95
Working Papers / Groupe d'Analyse et de Thorie Economique Lyon St-tienne (GATE Lyon St-tienne), Universit de Lyon6
Working Papers / HAL4

Recent works citing Lionel Perrier (2022 and 2021)


YearTitle of citing document

Works by Lionel Perrier:


YearTitleTypeCited
2009Transférabilité des évaluations de coûts en santé. Analyse des facteurs de variabilité In: Revue économique.
[Full Text][Citation analysis]
article0
2009Transférabilité des évaluations de coûts en santé : analyse des facteurs de variabilité.(2009) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 0
paper
2015A literature review to identify factors that determine policies for influenza vaccination In: Health Policy.
[Full Text][Citation analysis]
article6
2015A literature review to identify factors that determine policies for influenza vaccination.(2015) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 6
paper
2016Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants In: Health Policy.
[Full Text][Citation analysis]
article2
2016Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants.(2016) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 2
paper
2008Les évaluations de coûts en santé sont-elles transférables ? In: Working Papers.
[Full Text][Citation analysis]
paper0
2008Les évaluations de coûts en santé sont-elles transférables ?.(2008) In: Post-Print.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2008Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment In: Working Papers.
[Full Text][Citation analysis]
paper0
2008Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment.(2008) In: Post-Print.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2009The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer In: Working Papers.
[Full Text][Citation analysis]
paper0
2009The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer.(2009) In: Post-Print.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2013Literature review of the decision-making determinants related to the influenza vaccination policy In: Working Papers.
[Full Text][Citation analysis]
paper0
2013Literature review of the decision-­?making determinants related to the influenza vaccination policy.(2013) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2014Inégalités d’exposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France In: Working Papers.
[Full Text][Citation analysis]
paper0
2014Inégalités dexposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France.(2014) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2016Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France In: Working Papers.
[Full Text][Citation analysis]
paper0
2016Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France.(2016) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2017Toxicité et qualité de vie comparées après curiethérapie par iode 125 et radiothérapie stéréotaxique des cancers prostatiques [Toxicity and quality of life comparison of iodine 125 brachytherapy and s In: Post-Print.
[Citation analysis]
paper0
2004Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocol In: Post-Print.
[Citation analysis]
paper0
2005Trajectoires optimales des patients évoluant vers la dépendance In: Post-Print.
[Citation analysis]
paper0
2007The impact of CD34+ cell dose on the cost of HDT with PBSC transplantation in lymphomia In: Post-Print.
[Citation analysis]
paper0
2005A model to calculate treatment cost per protocol for light ion facility radiotherapy projects in Europe In: Post-Print.
[Citation analysis]
paper0
2007Assessing the generalisability of cost evaluation results using the euclidean metric and principal components analysis : Lesson from a high-cost innovation in oncology In: Post-Print.
[Citation analysis]
paper0
2005Report of work package 6 “Health economics aspects” In: Post-Print.
[Citation analysis]
paper0
2006The contribution of the simulation for innovative technologies: The case of the hadrontherapy In: Post-Print.
[Citation analysis]
paper0
2007Les évaluations de coûts en santé sont-elles transférables ? Mesures et application à une innovation très coûteuse en cancérologie In: Post-Print.
[Citation analysis]
paper0
2007Organisation et financement des soins : vers une inadéquation croissante ? In: Post-Print.
[Citation analysis]
paper0
2004Cost comparison of two surgical strategies in the treatment of breast cancer: Sentinel lymph node biopsy versus axillary lymph node dissection In: Post-Print.
[Citation analysis]
paper0
2002Vers une nécessaire harmonisation des évaluations de coûts en santé. Lexemple des intensifications thérapeutiques avec autogreffes de cellules souches du sang périphérique en France In: Post-Print.
[Citation analysis]
paper0
2008A Decision-making Tool for a Costly Innovative Technology: The Case of Carbon Ion Radiotherapy In: Post-Print.
[Citation analysis]
paper0
2009Cost-effectiveness analysis of compliance with clinical guidelines for sarcoma management In: Post-Print.
[Citation analysis]
paper0
2010Apports de lévaluation économique et de lanalyse dimpact budgétaire pour la décision publique en santé : lexemple du cancer du sein In: Post-Print.
[Citation analysis]
paper0
2010Cost-effectiveness analysis: methods and applications in oncology In: Post-Print.
[Citation analysis]
paper0
2011Costi del tratamento In: Post-Print.
[Citation analysis]
paper0
2011Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma In: Post-Print.
[Citation analysis]
paper0
2013Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma.(2013) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 0
paper
2013Cost Effectiveness of Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Lymphoma and Myeloma.(2013) In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
article
2011Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in adult patients with lymphoma and myeloma: cost-effectiveness evaluation alongside a randomized In: Post-Print.
[Citation analysis]
paper0
2010Impact of chemotherapy prescriptions and costs on survival in advanced or metastatic NSCLC: a single-institution study using an instrumental variables approach In: Post-Print.
[Citation analysis]
paper0
2011Adherence to practice guidelines for the management of patients with sarcoma: A cost-effectiveness assessment in two European regions In: Post-Print.
[Citation analysis]
paper0
2011Conformity with clinical practice guidelines for management of patients with sarcoma: a cost-effectiveness assessment in two European regions In: Post-Print.
[Citation analysis]
paper0
2011Apports de lévaluation médico-économique pour la décision publique en santé In: Post-Print.
[Citation analysis]
paper0
2012A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study) In: Post-Print.
[Citation analysis]
paper1
2012The use of economic evaluations in health decision-making at the macro level: a literature review In: Post-Print.
[Citation analysis]
paper1
2012Evaluation économique prospective de la radiothérapie guidée par limage des cancers de la prostate dans le cadre du programme national de Soutien aux Thérapeutiques Innovantes et Coûteuses In: Post-Print.
[Citation analysis]
paper0
2012Discordant diagnoses in sarcoma, GIST and desmoide tumour in France: results from the network RREPS In: Post-Print.
[Citation analysis]
paper0
2012Cluster analysis and principal component analysis to access the variability of data in cost evaluations: methods and applications in oncology In: Post-Print.
[Citation analysis]
paper0
2012A cost-analysis of image-guided radiation therapy (IGRT) in prostate cancer: results from a phase III clinical trial In: Post-Print.
[Citation analysis]
paper0
2012Cost-effectiveness analysis: an interdisciplinary research and methodological perspective In: Post-Print.
[Citation analysis]
paper0
2013Cost of prostate image-guided radiation therapy: Results of a randomized trial In: Post-Print.
[Citation analysis]
paper1
2013Cost of physical activity intervention during adjuvant chemotherapy in breast cancer: results of the randomized trial PASAPAS In: Post-Print.
[Citation analysis]
paper0
2013Curiethérapie : valorisation et aspects médico-économiques In: Post-Print.
[Citation analysis]
paper0
2013Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study In: Post-Print.
[Citation analysis]
paper0
2013Comprendre les analyses médico-économiques : intervention didactique à lintention des cliniciens In: Post-Print.
[Citation analysis]
paper0
2013A cost-analysis of stereotactic radiotherapy in lung cancer In: Post-Print.
[Citation analysis]
paper0
2014Economic burden of seasonal influenza B in France during winter 2010-2011 In: Post-Print.
[Citation analysis]
paper1
2012Economic burden of seasonal influenza B in France during winter 2010-2011.(2012) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 1
paper
2013Economic burden of seasonal influenza B in France during winter 2010-2011.(2013) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 1
paper
2014Les fortes expositions aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) sont-elles lapanage des emplois précaires et peu qualifiés ? In: Post-Print.
[Citation analysis]
paper0
2013Inégalités de lexposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : SUMER 2010 In: Post-Print.
[Citation analysis]
paper0
2009Costs and compliance with clinical practice guidelines: A pilot study for initial sarcoma treatment In: Post-Print.
[Citation analysis]
paper0
2014Cost-effectiveness of a Genetic Test for Breast Cancer Risk - Letter In: Post-Print.
[Citation analysis]
paper0
2014Inégalités de l’exposition aux produits chimiques cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de l’enquête SUMER In: Post-Print.
[Citation analysis]
paper0
2014Inégalités de lexposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France In: Post-Print.
[Citation analysis]
paper0
2014Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool In: Post-Print.
[Citation analysis]
paper0
2015Relationship between the development of electronic health records and hospital accreditation decisions in France: results from the E-SI (Preps-Sips) In: Post-Print.
[Citation analysis]
paper0
2015Health Information System Adoption And Hospital Accreditation Decisions In France: Results From The E-SI (PREPS-SIPS) Study In: Post-Print.
[Citation analysis]
paper0
2015A cost-consequence analysis of hepatitis B screening in an immigrant population In: Post-Print.
[Citation analysis]
paper0
2016Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study In: Post-Print.
[Citation analysis]
paper0
2015Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study.(2015) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 0
paper
2016A cost analysis of complex radiotherapy for patients with head and neck cancer In: Post-Print.
[Citation analysis]
paper0
2016Système dinformation et performance hospitalière In: Post-Print.
[Citation analysis]
paper0
2016Cost-Effectiveness Of Treatments For Mild-To-Moderate Obstructive Sleep Apnea In France In: Post-Print.
[Full Text][Citation analysis]
paper0
2016Dossier Patient Informatisé : quel impact sur la performance des établissements de santé en France ? In: Post-Print.
[Citation analysis]
paper0
2016Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands In: Post-Print.
[Citation analysis]
paper1
2016Toxicity and efficacy of cetuximab associated with several modalitiesof IMRT for locally advanced head and neck cancer In: Post-Print.
[Citation analysis]
paper0
2016A cost-effectiveness analysis of the ZIRA test in breast cancer In: Post-Print.
[Citation analysis]
paper0
2016Impact of health information systems on hospital bed occupancy rates in French hospitals: results from the e-SI (PREPS-SIPS) study In: Post-Print.
[Citation analysis]
paper0
2016A cost-effectiveness analysis of a 6-month physical activity program versus usual dietary care during adjuvant chemotherapy in breast cancer: An economic evaluation of the PASAPAS trial In: Post-Print.
[Citation analysis]
paper0
2017Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure In: Post-Print.
[Citation analysis]
paper0
2017Does adoption of electronic health records improve organizational performances of hospital surgical units? Results from the French e-SI (PREPS-SIPS) study In: Post-Print.
[Citation analysis]
paper1
2016Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis In: Post-Print.
[Citation analysis]
paper0
2017In Reply to Escande et al In: Post-Print.
[Citation analysis]
paper0
2016In Reply to Fodor and Di Muzio In: Post-Print.
[Citation analysis]
paper0
2016Why should we focus on a structured model of secure digital exchanges to incorporate new documents in electronic patient records? In: Post-Print.
[Citation analysis]
paper0
2016Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study In: Post-Print.
[Citation analysis]
paper0
2016General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France In: Post-Print.
[Citation analysis]
paper0
2016Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing In: Post-Print.
[Citation analysis]
paper0
2017Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France In: Post-Print.
[Citation analysis]
paper0
2016Guide méthodologique sur le costing à l’Hôpital In: Post-Print.
[Citation analysis]
paper0
2017Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003–10 In: Post-Print.
[Citation analysis]
paper0
2018Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation In: Post-Print.
[Citation analysis]
paper1
2017Assessment of a self-administered questionnaire identifying occupational exposures among lung cancer patients In: Post-Print.
[Full Text][Citation analysis]
paper0
2017Radiotherapy costs: the good, the bad and the ugly In: Post-Print.
[Citation analysis]
paper0
2017Analyse des corrélations entre informatisation et performance des établissements de santé In: Post-Print.
[Citation analysis]
paper0
2017Management of Febrile Neutropenias in Adolescents and Young Adults: A Cost-Minimization Analysis Between Adult Versus Pediatric Units In: Post-Print.
[Citation analysis]
paper0
2017Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis In: Post-Print.
[Citation analysis]
paper0
2017Does adoption of electronic health records improve the quality of care management in France? Results from the French e-SI (PREPS-SIPS) study In: Post-Print.
[Citation analysis]
paper0
2017Guide méthodologique sur le calcul et l’analyse des coûts hospitaliers In: Post-Print.
[Citation analysis]
paper0
2018In reply to Tallet et al. In: Post-Print.
[Citation analysis]
paper0
2018In reply to Jean-François Daisne, Sandra Nuyts, Fréderic Duprez and Benoît Bihin In: Post-Print.
[Citation analysis]
paper0
2017What Underlies The Observed Hospital Volume-Outcome Relationship? In: Post-Print.
[Citation analysis]
paper0
2017Cost of radiotherapy: what is the quality of the evidence found? Critical quality appraisal of studies estimating cost of radiotherapy In: Post-Print.
[Citation analysis]
paper0
2017Does adoption of electronic heath record improve the quality of care management? In: Post-Print.
[Citation analysis]
paper0
2017Does adoption of electronic records improve organizational performances of hospital surgical units? In: Post-Print.
[Citation analysis]
paper0
2018Being Treated In Higher Volume Hospitals Leads To Longer Progression-Free Survival For Epithelial Ovarian Carcinoma Patients in the Rhone-Alpes region of France In: Post-Print.
[Full Text][Citation analysis]
paper3
2017Les impacts médico-économiques de lévolution du parcours de soins en cancérologie In: Post-Print.
[Citation analysis]
paper0
2014Inégalités de lexposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de lenquête SUMER In: Working Papers.
[Citation analysis]
paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated August, 1st 2022. Contact: CitEc Team